Ruolin Li
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Parkinson's Disease Mechanisms and Treatments
Papers in
- Oncology 12
- Cancer Treatment and Pharmacology 4
- Inflammatory Biomarkers in Disease Prognosis 2
- Co-authors
- Hui Ling Yang (1 shared paper)Weijin Liu (1 shared paper)Jia Liu (1 shared paper)Xue Ying Qin (23 shared papers)Qiliu Peng (15 shared papers)Shan Li (9 shared papers)Xianjun Lao (8 shared papers)Hongjie Liang (5 shared papers)
- Journals
- Tumor Biology (7 papers)Diagnostic Pathology (4 papers)Supportive Care in Cancer (3 papers)Cancer Nursing (3 papers)PLoS ONE (2 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Ruolin Li
52 papers receiving 869 citations
Peers
Comparison fields: 5 of 112
- Cancer Research 131
- Neurology 86
- Oncology 114
- Epidemiology 144
- Pathology and Forensic Medicine 73
Countries citing papers authored by Ruolin Li
This map shows the geographic impact of Ruolin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruolin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruolin Li more than expected).
Fields of papers citing papers by Ruolin Li
This network shows the impact of papers produced by Ruolin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruolin Li. The network helps show where Ruolin Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruolin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 193 | |
| 2 | 2014 | 50 | |
| 3 | 2021 | 38 | |
| 4 | 2014 | 36 | |
| 5 | 2022 | 35 | |
| 6 | 2013 | 31 | |
| 7 | 2018 | 30 | |
| 8 | 2013 | 26 | |
| 9 | 2020 | 24 | |
| 10 | 2020 | 21 | |
| 11 | 2014 | 21 | |
| 12 | 2014 | 20 | |
| 13 | 2021 | 20 | |
| 14 | 2022 | 20 | |
| 15 | 2014 | 19 | |
| 16 | 2013 | 19 | |
| 17 | 2013 | 18 | |
| 18 | 2013 | 18 | |
| 19 | 2014 | 18 | |
| 20 | 2013 | 15 |
About Ruolin Li
Ruolin Li is a scholar working on Oncology, Cancer Research, Rheumatology, Endocrinology, Diabetes and Metabolism and Immunology, having authored 58 papers that have together received 882 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Hormonal Regulation and Hypertension (3 papers), DNA Repair Mechanisms (3 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers), Cancer-related cognitive impairment studies (2 papers), Vitamin D Research Studies (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Systemic Lupus Erythematosus Research (2 papers). The work is most often cited by research in Cancer Research (131 citations), Neurology (86 citations), Oncology (114 citations), Epidemiology (144 citations) and Pathology and Forensic Medicine (73 citations). Ruolin Li has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Hui Ling Yang, Weijin Liu, Jia Liu, Xue Ying Qin, Qiliu Peng, Shan Li, Xianjun Lao, Hongjie Liang, Taijie Li and Zhiping Chen. Their work appears in journals such as Tumor Biology, Diagnostic Pathology, Supportive Care in Cancer, Cancer Nursing and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.